Table 5. Antimicrobial susceptibility of S. aureus isolates from RT patients and reference strains from different upper respiratory tract-related outpatient clinics1 of the Rostock University Hospital in the years 2001–2007.
| n (%) susceptible S. aureus isolates | |||
| antibiotics | S. aureus strains of outpatients with RT n = 76 | S. aureus strains of patients from outpatient clinics1 n = 296 | p-value |
| penicillin | 25 (32.9) | 70 (23.6) | 0.1063 |
| Oxacillin | 75 (98.7) | 296 (100) | 0.2043 |
| cefuroxime | 75 (98.7) | 296 (100) | 0.2043 |
| levofloxacin | 75 (98.7) | 285 (96.3) | 0.4724 |
| moxifloxacin | 75 (98.7) | - | - |
| gentamicin | 75 (98.7) | 285 (96.3) | 0.4724 |
| streptomycin | 66 (86.8) | - | - |
| erythromycin | 70 (92.1) | 271 (91.6) | 1.000 |
| teicoplanin | 76 (100) | 296 (100) | 1.000 |
| vancomycin | 76 (100) | 296 (100) | 1.000 |
| cotrimoxacol | 76 (100) | 293 (99.0) | 1.000 |
| doxycycline | 71 (93.4) | 260 (87.8) | 0.2181 |
| clindamycin | 76 (100) | 284 (95.9) | 0.1366 |
1
The material was collected from outpatients presenting at the otolaryngology, ophthalmology, and oral and maxillofacial surgery clinics.